CoEN Montpellier

Equipes/Composantes labellisées

  


Clinical CoEN members (Montpellier University Hospital)

Short name

Team

Topic

Responsible/Contact

Email

CHRU / A1

Memory resource and research center, behavioral Neurology

Cognition and biomarkers for early diagnosis and prognosis of Alzheimer's disease

Audrey Gabelle

audreygabelle@hotmail.com

a-gabelle@chu-montpellier.fr

CHRU / A2

Department of Neurology

Inflammatory diseases of the nervous system and diseases of the white matter (multiple sclerosis)

Pierre Labauge

p-labauge@chu-montpellier.fr

labauge@yahoo.fr

CHRU / A3

Motor neuron clinic and pathologies neuromuscular, Motoneuron national reference center,

Genetics and therapy of amyotrophic lateral sclerosis.

William Camu

w-camu@chu-montpellier.fr

CHRU / A4

Parkinson Disease Expert Center

Parkinson in the Elderly, Age related Tremor, Gait disorders

Christian Geny

c-geny@chu-montpellier.fr

CHRU / A5

Center of competence for Huntington’s disease

Genetics and therapy of Huntington’s disease

Cecilia Marelli

c-marelli@chu-montpellier.fr

CHRU / A6

Sleep disorders unit and Reference Centre narcolepsy

Epidemiology, clinical neurophysiology, biomarkers, and therapy of sleep disorders.

Yves Dauvilliers

y-dauvilliers@chu-montpellier.fr

CHRU / B1

Gerontology department, Living Lab Frailty

Regional Evaluation Center of Frailty in the Elderly (CESAF)

Claude Jeandel

c-jeandel@chu-montpellier.fr

claudejeandel@yahoo.fr

CHRU / B2

Regional center for balances and prevention of falls

Falls, sarcopenia,

Hubert Blain

h-blain@chu-montpellier.fr

CHRU / C1

Functional Neurosurgery,

Dystonia, Parkinson and movement disorders deep brain stimulation therapies

Philippe Coubes

p-coubes@chu-montpellier.fr

CHRU / D1

Department of Psychiatry, Expert center of bipolar disorder

Suicide behavior, genetics, bipolar troubles

Philippe Courtet

p-courtet@chu-montpellier.fr

CHRU / D2

Department of Psychiatry, adult, University Service of Psychiatry adult

Schizophrenia: psychopathology in the treatment

Jean Philippe Boulenger, Delphine Capdevieille

jp-boulenger@chu-montpellier.fr

d-capdevielle@chu-montpellier.fr

CHRU / E1

Laboratory of Biochemistry – Clinical Proteomics

Biomarkers of neurological pathologies (quantitative Proteomics)

Sylvain Lehmann

s-lehmann@chu-montpellier.fr

CHRU / E2

Diagnostic using Neuroradiology, Department of Neuroradiology

Neurologic diseases and functional imaging

Alain Bonafe, V Costalat, N Menjot de Chamfleur

a-bonafe@chu-montpellier.fr

v-costalat@chu-montpellier.fr

n-menjot_de_champfleur@chu-montpellier.fr

CHRU / E3

Department of nuclear medicine

Diagnosis of neurological pathologies and search of new tracers to sight neurological (markers of amyloid plaques, postsynaptic receptors of dopamine...)

Denis Mariano-Goulart

d-mariano_goulart@chu-montpellier.fr

CHRU / E4

Genetic Department, Presymptomatic unit

Genetics, presymptomatic care

Pierre Sarda, Christine Coubes

p-sarda@chu-montpellier.fr

c-coubes@chu-montpellier.fr

CHRU / E5

Medical Information Department (DIM)

Data management, research regulatory

Marie-Christine PICOT

mc-picot@chu-montpellier.fr

  


Research team CoEN members (Montpellier University, UM3, INSERM, CNRS)

Short name

Team

Topic

Responsible/Contact

Email

Inserm U1061 / R1

Affective disorders: bio-environmental risk and resilience

Epidemiological and clinical cohort spirit

Marie-Laure Ancelin

marie-laure.ancelin@inserm.fr

Inserm U1061 / R2

Suicidal behaviour

Psychiatric vulnerability, suicidal behaviour

Philippe Courtet, Sébastien Guillaume

p-courtet@chu-montpellier.fr, philippe.courtet@univ-montp1.fr,  s-guillaume@chu-montpellier.fr

Inserm U1061 / R3

Age-related cognitive disorders

Multicentre research on vascular risk factors and cerebral aging.

Claudine Berr

claudine.berr@inserm.fr

Inserm U1061 / R4

Sleep disorders

Epidemiology and mechanisms of disorders of sleep in the elderly

Yves Dauvilliers

y-dauvilliers@chu-montpellier.fr

Inserm U1061 / R5

Platform of biostatistical modelling

Statistical modelling methods for the exploitation of the epidemiological and clinical data

Isabelle Carrière

isabelle.carriere@inserm.fr

Inserm U1183 / R1

Genome and stem cell plasticity in development and ageing

Basic genetic and epigenetic mechanisms underlying tissue regeneration

Jean-Marc Lemaitre

jean-marc.lemaitre@inserm.fr

Inserm U1183 / R2

Neural stem cells, MSC and neurodegenerative diseases

Neural Stem Cell, MSC and iPS in Neurodegenerative Diseases

Carole Crozet, Sylvain Lehmann

carole.crozet@inserm.fr, sylvain.lehmann@inserm.fr

UMR 1051 / R1

Motoneurone disease: Neuroinflammation and therapy

Mechanisms and therapies for ALS

Cédric Raoul

cedric.raoul@inserm.fr

UMR 1051 / R2

The microglial signature in ALS

Role of microglia and their molecular crosstalk with motoneurons in ALS

Florence Perrin

florence.perrin@inserm.fr

UMR 1051 / R3

Deafness, tinnitus and therapies.

 

Jean-Luc Puel

Jean-luc.puel@inserm.fr

UMR 1051 / R3

Neurodegeneration and degradation system

The Ubiquitine Proteasome system in neurodegeneration and cytoskeleton architecture

Pascale Bomont

pascale.bomont@inserm.fr

UMR 1051 / R4

Deafness, tinnitus and therapies.

Study of the mechanisms of deafness and tinnitus to envision therapies.

Jean-Luc Puel

Jean-luc.puel@inserm.fr

IGF / R1

Neuroreceptor, dynamics, and function

Modulation of the mGlu and GABA receptor activity.

Jean-Philippe Pin, Laurent Prezeau

laurent.prezeau@igf.cnrs.fr

IGF / R2

Neuroproteomics and signs of neurological and psychiatric diseases

Biomarkers of neurological diseases

Philippe Marin

philippe.marin@igf.cnrs.fr

IGF / R3

New families of ion channels

receptors, purinergic and neurodegenerative and inflammatory diseases

François Rassendren

francois.rassendren@igf.cnrs.fr

IGF / R4

Normal and pathological neurobiology in drosophila

molecular and cellular networks for Tau and Huntingtin

Marie-Laure Parmentier

Marie-Laure.Parmentier@igf.cnrs.fr

IGF / R5

Neural circuits and signal transduction

Molecular and cellular networks for dopamine and glutamate signals

Emmanuel Valjent

emmanuel.valjent@igf.cnrs.fr

IGF / R6

Cell cycle clock genomics, C3G

molecular and cellular networks

Frédéric Bienvenu

frederic.bienvenu@igf.cnrs.fr

IGF / R7

Tracking diseases trajectories

Cell network plasticity in CNS diseases

Freddy Jeanneteau

Freddy.Jeanneteau@igf.cnrs.fr

IGF / R8

Physiopathology of the synaptic transmission 

Study of the molecular processes involved in the physiological neuronal communication and deficiencies leading to neurodegenerative processes

Julie Perroy

Julie.Perroy@igf.cnrs.fr

IGF / R9

Cerebrovascular Mechanisms of Brain Disorders

Study of the relevance of cerebrovascular damage in i) the progression of neuro-inflammation and degeneration ii) the pathological brain-to-periphery exchanges

Nicola Marchi

nicola.marchi@igf.cnrs.fr

Inserm U1198 / R1

Brain aging and neurodegenerative pathologies

Study of brain aging in primates lemur Microcebus murinus (Mouse Lemur)

Jean-Michel Verdier

jean-michel.verdier@univ-montp2.fr

Inserm U1198 / R2

Endogenous Neuroprotection in neurodegenerative diseases

Therapeutic approaches on non-transgenic models of Alzheimer's disease

Maurice Tangui

maurice@univ-montp2.fr

Inserm U1198 / R3

Huntington's disease: Neurophysiopathology from Drosophila to mice

neuroprotective properties of the peptide P42 from the huntingtin protein.

Florence Maschat

florence.maschat@univ-montp2.fr

Inserm U1198 / R4

Life history of longevity and vitality

Etiology of cerebral aging from data from epidemiological cohort

Jean-Marie Robine

robinejm@gmail.com

Inserm U1198 / R5

Environmental impact on Alzheimer’s disease and related disorders

Impact of exogenous perturbations, on the etiology on AD and related diseases

Catherine Desrumaux, Laurent Givalois

catherine.desrumaux@univ-montp2.fr

lgivalois@univ-montp2.fr

IGH / R1

Neurogenetics and Memory

Understanding of the physiological role of APP

Jean-Maurice Dura

jean-maurice.dura@igh.cnrs.fr

IGH / R2

Tubulin Code

Microtubule dynamics in Neurodegeneration

Krzysztof Rogowski

Krzysztof.Rogowski@igh.cnrs.fr

IGMM / R1

Adenovirus : Receptors, Trafficking and Vectorology

Vector for gene transfer to the CNS

Eric J Kremer

eric.kremer@igmm.cnrs.fr

CRBM-CNRS/R1

Signaling and cytoskeleton dynamics

Role of rho GTPases in brain development and neurodevelopmental diseases

Anne Debant

anne.debant@crbm.cnrs.fr

IGMM / R2

Molecular Mechanisms of Apoptosis Regulation

Characterization of signaling pathways that control the survival/death fate of neurons.

Solange Desagher

solange.desagher@igmm.cnrs.fr

EA 4556 / R1

Epsilon Laboratory EVOLVE team

To evaluate the question of psychosocial factors implied in the preservation or the damages of cognitive, physical functions and the psychological well-being in the elderly.

Marie-Christine Gely-Nargeot

marie-christine.gely-nargeot@univ-montp3.fr

EFS/R1

Diagnostic and therapeutic innovation

Study of chronic infection (prion, Zika, VIH)

Chantal Fournier-Wirth

Chantal.Fournier@efs.sante.fr

 

 

Vous recherchez
Prendre rendez-vous
Examens
Prises en charge spécifiques
Numéros d'urgence
Samu
Samu
###POMPIERS_IMG_ALT###
Pompiers
Croix Rouge des urgences
Tous les numéros
Localiser

CHU de Montpellier

191 avenue du Doyen Gaston Giraud
34090 Montpellier

Actualités
Semaine de la sécurité patients du 18 au 22 novembre 2019
Félicitations au Professeur Hugues DUFFAU
[Mois Sans Tabac] : Et si vous arrêtiez ?
Agenda
Venez nous rejoindre sur les stands pour rencontrer les associations, tester votre souffle, chercher de l'information sur la BPCO. Participez à une séance d'Activité Physique Adaptée.
Films, Jeux, quizz, flyers, simulation active… Pour tout savoir sur l'utilisation des antibiotiques
Docuthèque

TEC & ARC hospitaliers TEC & ARC hospitaliers, les essais cliniques même combat ou presque ! > Télécharger pdf - 276Ko

> Tous les documents